Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
CJC 1295 (mod GRF 1-29) (3mg) + Ipamorelin (4.5mg) Blend $82.50 Research Use Notice This product is supplied for laboratory research use only and is not intended for human use
Pre-training injection risks glucose partitioning toward glycogen synthesis rather than structural protein accretion the body prioritizes energy substrate restoration before muscle protein synthesis
Neuron 93:12961313 Sun Y, Shu Y, Liu B, Liu P, Wu C, Zheng R, Zhang X, Zhuang Z, Deng Y, Zheng L, Xu Q, Jiang B, Ouyang X, Gao J, Xu N, Li X, Jiang S, Liang C, Yao Y (2016) A prospective study to evaluate the efficacy and safety of oral acetyl-l-carnitine for the treatment of chemotherapy-induced peripheral neuropathy
No regulatory body Health Canada, the FDA, the EMA, the TGA, or any equivalent has approved either component compound, or the blend formulation, as a drug for human or veterinary use
